Literature DB >> 27249422

Topical treatment with a two-component gel releasing nitric oxide cures C57BL/6 mice from cutaneous leishmaniasis caused by Leishmania major.

Florian Butsch1, Beate Lorenz1, Alfred Goldinger1,2, Esther von Stebut3.   

Abstract

Entities:  

Keywords:  Th1/2; leishmaniasis; nitric oxide; treatment

Mesh：

Substances：

Year:  2016        PMID： 27249422     DOI： 10.1111/exd.13098

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN： 0906-6705            Impact factor:   3.960


× No keyword cloud information.
  2 in total

Review 1.  [Leishmaniasis : Diagnosis and therapy].

Authors:  E von Stebut
Journal:  Hautarzt       Date:  2017-07       Impact factor: 0.751

2.  Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.

Authors:  Mahmoud Reza Jaafari; Mahdi Hatamipour; Seyedeh Hoda Alavizadeh; Azam Abbasi; Zahra Saberi; Sima Rafati; Yasaman Taslimi; Akram Miramin Mohammadi; Ali Khamesipour
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-09-23       Impact factor: 4.077
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.